相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
相关阅读
AI 赋能培养基定制开发:CHO 培养基是如何实现产量提升Cytoscape 教程来了!快速实现顶刊同款通路网络图五大应用案例:Mustang Q 膜层析应用全解析1 个小工具,一次性搞定流程图、质粒图谱和信号通路图- 详细信息
- 文献和实验
- 技术资料
- 应用范围:
ELISA;Western Blotting
- 宿主:
Rabbit
- 库存:
大量
- 适应物种:
Human
- 抗原来源:
0
- 是否单克隆:
2
- 规格:
50 μg
| Species Reactivity | Key Applications | Host | Format | Antibody Type |
|---|---|---|---|---|
| H | ELISA, WB | Rabbit | Affinity Purified | Polyclonal Antibody |
SPECIES REACTIVITIES: The antibody has not yet been tested for cross-reactivity to other species. The sequence used for immunization shows 100% homology to mouse and rat UCP2 and 92% homology with canine, porcine and bovine.
- ELISA
- Western Blotting
Immunohistochemistry: Has not been tested. It is recommended that you use 2-20 μg/mL on formaldehyde fixed tissue.
ELISA: 1:10,000-1:100,000; using 50-100 ng UCP2 control peptide/well.
Optimal working dilutions must be determined by end user.
- UCP2
- UCPH
- SLC25A8
更多产品技术资讯,请访问密理博中国博客:http://blog.milliporechina.com
13 aa peptide sequence near the 3rd and 4th transmembrane domain of human UCP2 (Fleury et al. 1997; Gimeon et al. 1997). The peptide has no significant homology with UCP1, UCP3 or UCP4 (Boss et al. 1997). 详细描述见链接:http://www.millipore.com/catalogue/item/AB3226
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验抗原呈递不足 + 免疫逃逸?级联响应肽自组装技术破局!Absin 助力肿瘤免疫联合治疗新突破
Co-Delivery of T-Cell Antigen and Camptothecin Guided by Cascade-Responsive Peptide Self-Assembly to Reshape Tumor Antigenicity for Cancer Immunotherapy 发表期刊:Advanced Materials(IF 26.8) | DOI: 使用 Absin 产品:Rabbit anti-CD274 Polyclonal Antibody(abs115675)、抗
。下面是来自使用者的反馈数据: 1、蛋白含量低,得到的WB信号弱--SignalBoostTM可以增强信号,检测到低丰度蛋白: 样品:K562细胞全细胞裂解液。 (Lane 1: 25μg总蛋白;Lane 2: 5μg总蛋白;Lane 3: 2.5μg总蛋白) 一抗:anti-PKC(Ab-2)小鼠单抗(MC5)(货号OP74),分别用5%脱脂奶粉PBST溶液(图A)和SignalBoost Solution 1(图B)按照1:1000比例稀释。 二抗:Rabbit anti
Recombinant Rabbit mAb (Alexa Fluor® 647 conjugate) (S-712-10) 二、抗独特型抗体(Anti-idiotype antibody) 抗独特型抗体更适合单一CAR 骨架的深度表征,它识别scFv可变区的专属独特表位,具有极强的靶点特异性,仅识别特定scFv序列构建的CAR,几乎不存在交叉反应。目前市面上已有多款成熟商业化抗独特型抗体,分别识别临床广泛使用的CAR scFv克隆,包括识别FMC63 scFv(CD19 CAR-T)、人源2C6 scFv
技术资料暂无技术资料 索取技术资料






